Chemical Compound

Cabotegravir sodium

CAS Registry Number 1051375-13-3
Cabotegravir sodium chemical structure
Primary Record

Cabotegravir sodium

In stock
4,866 g
Purity
99.5 %
CAS
1051375-13-3

Compound Identifiers & Properties

CAS
1051375-13-3
PubChem CID
46215800
SMILES
C[C@H]1CO[C@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)[O-].[Na+]
Canonical SMILES
C[C@H]1CO[C@@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c([O-])c3C(=O)N12.[Na+]

Names & Synonyms

  • Cabotegravir sodium
  • Vocabria
  • Cabotegravir-sodium
  • Cabotegravir (sodium)
  • Vocabria (TN)
  • Cabotegravir Sodium?
  • Cabotegravir sodium [USAN]
  • 1051375-13-3
  • GSK1265744B
  • RefChem:54589
  • GSK-1265744B
  • UNII-3L12PT535M
  • 3L12PT535M
  • UNII-HMH0132Z1Q
  • S-265744B
  • C19H16F2N3NaO5
  • CHEBI:172948
  • orb1908995
  • CHEMBL3137330
  • SCHEMBL29393452
  • Cabotegravir sodium (JAN/USAN)
  • CABOTEGRAVIR SODIUM [JAN]
  • S 265744B
  • AMY30044
  • CABOTEGRAVIR SODIUM [WHO-DD]
  • EBC-97034
  • GSK 1265744B
  • HY-15592A
  • ACN-041361
  • CABOTEGRAVIR SODIUM [ORANGE BOOK]
  • AC-30853
  • DA-51525
  • CS-0007799
  • D10549
  • F11513
  • Sodium (3S,11aR)-8-((2,4-difluorobenzyl)carbamoyl)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate
  • A935003
  • Q27257476
  • Oxazolo(3,2-a)pyrido(1,2-d)pyrazine-8-carboxamide, N-((2,4-difluorophenyl)methyl)-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-, sodium salt (1:1), (3S,11aR)-
  • Sodium (3S,11aR)-8-(((2,4-difluorophenyl)methyl)carbamoyl)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo(3,2-a)pyrido(1,2-d)pyrazin-6-olate
  • sodium;(3R,6S)-12-[(2,4-difluorophenyl)methylcarbamoyl]-6-methyl-8,11-dioxo-4-oxa-1,7-diazatricyclo[7.4.0.03,7]trideca-9,12-dien-10-olate
  • (3S,11aR)-N-(2,4-Difluorobenzyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide, sodium salt
  • 857-514-0
  • Cabotegravir sodium|1051375-13-3|GSK1265744B|GSK-1265744B|UNII-3L12PT535M|Cabotegravir (sodium)|S-265744B|S 265744B|3L12PT535M|Vocabria|Sodium (3S,11aR)-8-((2,4-difluorobenzyl)carbamoyl)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate|Cabotegravir sodium [USAN]|CHEMBL3137330|Cabotegravir sodium (JAN/USAN)|CHEBI:172948|AMY30044|GSK 1265744B|HY-15592A|AC-30853|Oxazolo(3,2-a)pyrido(1,2-d)pyrazine-8-carboxamide, N-((2,4-difluorophenyl)methyl)-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-, sodium salt (1:1), (3S,11aR)-|Sodium (3S,11aR)-8-(((2,4-difluorophenyl)methyl)carbamoyl)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo(3,2-a)pyrido(1,2-d)pyrazin-6-olate|CS-0007799|D10549|F11513|A935003|Q27257476|(3S,11aR)-N-(2,4-Difluorobenzyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide, sodium s
  • sodium (3S,11aR)-8-[(2,4-difluorobenzyl)carbamoyl]-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate
  • Sodium (3S,11aR)-8-{[(2,4-difluorophenyl)methyl]carbamoyl}-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate
  • Sodium(3S,11aR)-8-((2,4-difluorobenzyl)carbamoyl)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate